Veeva Systems Inc
NYSE:VEEV

Watchlist Manager
Veeva Systems Inc Logo
Veeva Systems Inc
NYSE:VEEV
Watchlist
Price: 242 USD -0.12% Market Closed
Market Cap: 39.7B USD

Veeva Systems Inc
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Veeva Systems Inc
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Veeva Systems Inc
NYSE:VEEV
Cash & Cash Equivalents
$1.7B
CAGR 3-Years
24%
CAGR 5-Years
21%
CAGR 10-Years
31%
Inspire Medical Systems Inc
NYSE:INSP
Cash & Cash Equivalents
$112.8m
CAGR 3-Years
-35%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Cash & Cash Equivalents
$209.6m
CAGR 3-Years
23%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Cash & Cash Equivalents
$180.1m
CAGR 3-Years
-12%
CAGR 5-Years
-22%
CAGR 10-Years
12%
Certara Inc
NASDAQ:CERT
Cash & Cash Equivalents
$179.2m
CAGR 3-Years
-1%
CAGR 5-Years
44%
CAGR 10-Years
N/A
W
Waystar Holding Corp
NASDAQ:WAY
Cash & Cash Equivalents
$182.1m
CAGR 3-Years
57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Veeva Systems Inc
Glance View

Veeva Systems Inc., born in the heart of Silicon Valley in 2007, embarked on its journey with a clear mission: to revolutionize the pharmaceutical and life sciences industries with cloud-based solutions. Founded by Peter Gassner, who previously held leadership roles at Salesforce and PeopleSoft, Veeva identified a niche opportunity amid the highly-regulated, complex landscape of healthcare. The company began by offering Customer Relationship Management (CRM) software tailored for the life sciences sector, allowing clients to stay compliant with industry regulations while efficiently managing relationships across the intricate healthcare network. Veeva’s CRM solutions gradually became instrumental for pharmaceutical and biotech companies in conducting their marketing, sales, and collaboration activities. As Veeva expanded, it diversified its portfolio by delving into other digital solutions, such as data management and analytics, content management, and regulatory and compliance software. Its Vault platform stood out, providing a unified suite for managing a vast array of business processes and content across powerful cloud applications. This approach enabled Veeva to serve its clientele throughout the drug development lifecycle, from research and development to commercialization. By adopting a subscription-based pricing model, Veeva ensured a steady revenue stream while continuously enhancing its offerings, solidifying its position as both a trusted partner and a critical component of its clients’ operational infrastructure. Through these strategic expansions, Veeva Systems Inc. not only adapted to the evolving demands of the healthcare sector but also reinforced its dominance in the specialized domain of life sciences cloud technology.

VEEV Intrinsic Value
161.41 USD
Overvaluation 33%
Intrinsic Value
Price

See Also

What is Veeva Systems Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
1.7B USD

Based on the financial report for Oct 31, 2025, Veeva Systems Inc's Cash & Cash Equivalents amounts to 1.7B USD.

What is Veeva Systems Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
31%

Over the last year, the Cash & Cash Equivalents growth was 59%. The average annual Cash & Cash Equivalents growth rates for Veeva Systems Inc have been 24% over the past three years , 21% over the past five years , and 31% over the past ten years .

Back to Top